Literature DB >> 9422080

Growth-regulative activity of human alpha-fetoprotein for different types of tumor and normal cells.

E Dudich1, L Semenkova, E Gorbatova, I Dudich, L Khromykh, E Tatulov, G Grechko, G Sukhikh.   

Abstract

The dose-dependent alpha-fetoprotein (AFP) reactivity of different types of tumor cells and normal embryonal fibroblasts, which are capable of taking up AFP, was investigated. High doses (more than 100 micrograms/ml) of purified human AFP were shown to induce strongly dose-dependent growth inhibition of human hepatoma HepG2 cells, human lymphoblastoma MT4 cells, lymphoma Jurkat cells and murine fibroblastoma L929 cells. Human mammary carcinoma MCF-7 cells also revealed a growth inhibitory response to AFP, although to a lesser extent. Equivalent doses of human serum albumin (HSA) demonstrated no effect on these cells. On the contrary, normal embryonal fibroblasts of different organ origin showed dose-dependent stimulation (50-90%) of proliferation in response to AFP. A similar stimulative effect was obtained when embryonal fibroblasts were treated with the same doses of HSA. The myeloblastoma cell line U-937 and the normal epidermal fibroblast cell line M19 were shown to be resistant to the AFP action over a wide range of protein concentrations. It was demonstrated that growth factor deprivation (i.e. low serum concentration) could stimulate U-937 cell proliferation in response to high doses of AFP. It was also shown that intensive washing of U-937 and MCF-7 cells with fresh medium to remove secreted cytokines and growth factors distinctly increased cell sensitivity to high-dose-AFP-induced growth-inhibitory activity. Low AFP concentrations (less than 100 micrograms/ml) failed to induce growth inhibition in all studied cells and rather showed a slight stimulative effect. These findings demonstrate that physiological levels of AFP can exhibit a dose-dependent growth-regulatory activity toward sensitive tumor or developing cells. Our data demonstrated that AFP could reveal either stimulative or inhibitory growth activity, depending on the relative concentration of AFP and on exogenous or endogenous cytokines and growth factors in the cell culture medium. A growth-stimulative activity in normal embryonal fibroblasts and certain tumor cell lines exhibited by low AFP concentrations is supposed to result from the synergistic effects of AFP and various other secreted growth factors.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9422080     DOI: 10.1159/000029972

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  17 in total

1.  Establishment of an alpha-fetoprotein-producing cell line derived from gastric cancer.

Authors:  M Matsuda; A Watanabe; H Sawada; Y Yamada; H Nakano; M Iwai; Y Iwai
Journal:  In Vitro Cell Dev Biol Anim       Date:  1999 Nov-Dec       Impact factor: 2.416

2.  Villin 1 is a predictive factor for the recurrence of high serum alpha-fetoprotein-associated hepatocellular carcinoma after hepatectomy.

Authors:  Maimaiti Xieraili; Mahmut Yasen; Kaoru Mogushi; Gulanbar Obulhasim; Abudureheman Mayinuer; Arihiro Aihara; Shinji Tanaka; Hiroshi Mizushima; Hiroshi Tanaka; Shigeki Arii
Journal:  Cancer Sci       Date:  2012-05-25       Impact factor: 6.716

3.  Alpha-fetoprotein triggers hepatoma cells escaping from immune surveillance through altering the expression of Fas/FasL and tumor necrosis factor related apoptosis-inducing ligand and its receptor of lymphocytes and liver cancer cells.

Authors:  Meng-Sen Li; Qiu-Ling Ma; Qian Chen; Xin-Hua Liu; Ping-Feng Li; Guo-Guang Du; Gang Li
Journal:  World J Gastroenterol       Date:  2005-05-07       Impact factor: 5.742

4.  Presence of Fas and Bcl-2 proteins in BEL-7404 human hepatoma cells.

Authors:  Xing-Wang Wang; Hong Xie
Journal:  World J Gastroenterol       Date:  1998-12       Impact factor: 5.742

5.  The promoting molecular mechanism of alpha-fetoprotein on the growth of human hepatoma Bel7402 cell line.

Authors:  Meng-Sen Li; Ping-Feng Li; Shi-Peng He; Guo-Guang Du; Gang Li
Journal:  World J Gastroenterol       Date:  2002-06       Impact factor: 5.742

6.  Heat shock protein 70 chaperoned alpha-fetoprotein in human hepatocellular carcinoma cell line BEL-7402.

Authors:  Xiao-Ping Wang; Qiao-Xia Wang; Hai-Yan Li; Rui-Fen Chen
Journal:  World J Gastroenterol       Date:  2005-09-21       Impact factor: 5.742

7.  Characterization of surface modification on self-assembled monolayer-based piezoelectric crystal immunosensor for the quantification of serum α-fetoprotein.

Authors:  Yu-Chang Tyan; Ming-Hui Yang; Tze-Wen Chung; Wen-Cheng Chen; Ming-Chen Wang; Yi-Ling Chen; Shu-Ling Huang; Ying-Fong Huang; Shiang-Bin Jong
Journal:  J Mater Sci Mater Med       Date:  2011-04-09       Impact factor: 3.896

8.  Alpha-fetoprotein contributes to THP-1 cell invasion and chemotaxis via protein kinase and Gi-protein-dependent pathways.

Authors:  Ekaterina Zubkova; Lidiya Semenkova; Elena Dudich; Igor Dudich; Yelena Parfyonova; Mikhail Menshikov
Journal:  Mol Cell Biochem       Date:  2013-04-25       Impact factor: 3.396

9.  Computational design and experimental discovery of an antiestrogenic peptide derived from alpha-fetoprotein.

Authors:  Karl N Kirschner; Katrina W Lexa; Amanda M Salisburg; Katherine A Alser; Leroy Joseph; Thomas T Andersen; James A Bennett; Herbert I Jacobson; George C Shields
Journal:  J Am Chem Soc       Date:  2007-04-19       Impact factor: 15.419

10.  Alpha-fetoprotein stimulated the expression of some oncogenes in human hepatocellular carcinoma Bel 7402 cells.

Authors:  Meng-Sen Li; Ping-Feng Li; Qian Chen; Guo-Guang Du; Gang Li
Journal:  World J Gastroenterol       Date:  2004-03-15       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.